Literature DB >> 22052890

Fatal outcomes in family transmission of Mycoplasma pneumoniae.

T R Kannan1, R D Hardy, J J Coalson, D C Cavuoti, J D Siegel, M Cagle, O Musatovova, C Herrera, J B Baseman.   

Abstract

BACKGROUND: Mycoplasma pneumoniae continues to be a significant cause of community-acquired pneumonia and, on rare occasions, manifests as fulminant disease that leads to mortality, even in healthy individuals.
METHODS: We conducted a retrospective study on members of a family who were quarantined by the Centers for Disease Control and Prevention in 2002 for respiratory failure and death of a 15-year-old brother (sibling 1) and a 13-year-old sister (sibling 2). Collected airway, cerebrospinal fluid (CSF), and serum samples from both deceased siblings and serum samples from both parents and the remaining 3 ill siblings (sibling 3-5) were tested using a range of diagnostic assays. Autopsy lung tissue samples from sibling 2 were also assessed using immunohistochemical and immunoelectron microscopic methods.
RESULTS: Autopsy evaluation of sibling 1 revealed cerebral edema consistent with hypoxic ischemic encepatholopathy and pulmonary findings of bronchiolitis obliterans with organizing pneumonia (BOOP). Postmortem lung examination of sibling 2 revealed lymphoplasmacytic bronchiolitis with intraluminal purulent exudate, BOOP, and pulmonary edema. Results of diagnostic assays implicated the household transmission of M. pneumoniae among all 5 siblings and both parents. Further analysis of lung tissue from sibling 2 demonstrated the presence of M. pneumoniae organisms and community-acquired respiratory distress syndrome toxin. M. pneumoniae was cultured directly from sibling 2 autopsy lung tissue.
CONCLUSION: Evidence is provided that M. pneumoniae was readily transmitted to all members of the household and that the resulting infections led to a spectrum of individual responses with variation in disease progression, including lymphoplasmacytic bronchiolitis, BOOP, and death.

Entities:  

Mesh:

Year:  2011        PMID: 22052890      PMCID: PMC3245726          DOI: 10.1093/cid/cir769

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control.

Authors:  Dominique Ursi; Kristien Dirven; Katherine Loens; Margareta Ieven; Herman Goossens
Journal:  J Microbiol Methods       Date:  2003-10       Impact factor: 2.363

2.  Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung.

Authors:  J C Maisel; L H Babbitt; T J John
Journal:  JAMA       Date:  1967-10-23       Impact factor: 56.272

3.  Mycoplasma pneumoniae pneumonia. Symptoms mimicking pulmonary embolism with infarction.

Authors:  B P Simmons; R C Aber
Journal:  JAMA       Date:  1979-03-23       Impact factor: 56.272

4.  Adult respiratory distress syndrome caused by Mycoplasma pneumoniae.

Authors:  R A Fischman; K E Marschall; J W Kislak; D M Greenbaum
Journal:  Chest       Date:  1978-10       Impact factor: 9.410

5.  Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection.

Authors:  G Biberfeld
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

6.  Mycoplasma pneumoniae associated organising pneumonia in a 10 year old boy.

Authors:  O Wachowski; S Demirakça; K-M Müller; W Scheurlen
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

7.  ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens.

Authors:  T R Kannan; Joel B Baseman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Chronic interstitial pulmonary fibrosis following Mycoplasma pneumoniae pneumonia.

Authors:  O C Tablan; M P Reyes
Journal:  Am J Med       Date:  1985-08       Impact factor: 4.965

10.  Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature.

Authors:  R J Koletsky; A J Weinstein
Journal:  Am Rev Respir Dis       Date:  1980-09
View more
  20 in total

1.  Acute respiratory distress syndrome caused by Mycoplasma pneumoniae without elevated pulmonary vascular permeability: a case report.

Authors:  Naoki Takahashi; Tsutomu Shinohara; Rie Oi; Muneyuki Ota; Shinichi Toriumi; Fumitaka Ogushi
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 2.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Disulfide bond of Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin is essential to maintain the ADP-ribosylating and vacuolating activities.

Authors:  Sowmya Balasubramanian; Lavanya Pandranki; Suzanna Maupin; Kumaraguruparan Ramasamy; Alexander B Taylor; Peter John Hart; Joel B Baseman; Thirumalai R Kannan
Journal:  Cell Microbiol       Date:  2019-05-09       Impact factor: 3.715

4.  Mycoplasma pneumoniae in children with acute and refractory asthma.

Authors:  Pamela R Wood; Vanessa L Hill; Margaret L Burks; Jay I Peters; Harjinder Singh; Thirumalai R Kannan; Shruthi Vale; Marianna P Cagle; Molly F R Principe; Joel B Baseman; Edward G Brooks
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02-23       Impact factor: 6.347

5.  Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.

Authors:  Thirumalai R Kannan; Manickam Krishnan; Kumaraguruparan Ramasamy; Argentina Becker; Olga N Pakhomova; P John Hart; Joel B Baseman
Journal:  Mol Microbiol       Date:  2014-07-10       Impact factor: 3.501

6.  Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in Children.

Authors:  Patrick M Meyer Sauteur; Selina Krautter; Lilliam Ambroggio; Michelle Seiler; Paolo Paioni; Christa Relly; Riccarda Capaul; Christian Kellenberger; Thorsten Haas; Claudine Gysin; Lucas M Bachmann; Annemarie M C van Rossum; Christoph Berger
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

7.  Mycoplasma pneumoniae Genotypes and Clinical Outcome in Children.

Authors:  Christoph Berger; Roger Dumke; Patrick M Meyer Sauteur; Elena Pánisová; Michelle Seiler; Martin Theiler
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

8.  Mycoplasma pneumoniae P1 Genotype Indicates Severity of Lower Respiratory Tract Infections in Children.

Authors:  Jasna Rodman Berlot; Uroš Krivec; Tatjana Mrvič; Rok Kogoj; Darja Keše
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

9.  Mycoplasma pneumoniae large DNA repetitive elements RepMP1 show type specific organization among strains.

Authors:  Oxana Musatovova; T R Kannan; Joel B Baseman
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

Review 10.  Infection with and Carriage of Mycoplasma pneumoniae in Children.

Authors:  Patrick M Meyer Sauteur; Wendy W J Unger; David Nadal; Christoph Berger; Cornelis Vink; Annemarie M C van Rossum
Journal:  Front Microbiol       Date:  2016-03-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.